Statistical analysis
REGRESSION, EVENT, RECURRENCE
Analyses will be performed according to the intention-to-treat principle. Patients who are lost or die before completing the 3-month follow-up visit will be excluded from the analysis of the primary endpoint. The proportions of patients with recurrence at follow-up in the dapagliflozin group and the placebo group will be compared using the chi-square test. In general, the last date of contact for each patient will be considered the censoring date for those without any primary outcome event. The cumulative incidence of the first occurrence of any event in the primary endpoint will be plotted by the Kaplan–Meier curve. In addition, the logistic regression model will be used to assess possible predictors for recurrence at follow-up, and pre-specified relevant clinical characteristics will be tested first in a univariate and then in a multivariate-adjusted model.Continuous variables will be expressed as the mean ± standard deviation or the median and the interquartile range, and Student’s 